4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-25-000140
Director acquired 6,037 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X05/wk-form4_1749155428.xml…